$17,100.00
0.00%
Nasdaq, Fri, Dec 27 2024
ISIN
US6760791060
Symbol
ODT
Sector
Industry

Odonate Therapeutics, Inc. Stock price

$17,100.00
+50.00 0.29% 1M
+0.00 0.00% 6M
+2,100.00 14.00% YTD
+2,100.00 14.00% 1Y
+2,300.00 15.54% 3Y
-278,100.00 94.21% 5Y
-212,900.00 92.57% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.00 0.00%
ISIN
US6760791060
Symbol
ODT
Sector
Industry

Key metrics

Market capitalization $65.82m
Enterprise Value $20.39m
EV/FCF (TTM) EV/FCF negative
Short interest 2.30%

Is Odonate Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Odonate Therapeutics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Odonate Therapeutics, Inc. forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Odonate Therapeutics, Inc. forecast:

Buy
100%

Financial data from Odonate Therapeutics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Annually
Dec '23
+/-
%
- -
-
100%
- Direct Costs 0.02 0.02
94% 94%
-
-0.02 -0.02
94% 94%
-
- Selling and Administrative Expenses 0.78 0.78
76% 76%
-
- Research and Development Expense - -
-
-
-0.80 -0.80
78% 78%
-
- Depreciation and Amortization 0.02 0.02
94% 94%
-
EBIT (Operating Income) EBIT -0.82 -0.82
79% 79%
-
Net Profit 7.33 7.33
83% 83%
-

In millions USD.

Don't miss a Thing! We will send you all news about Odonate Therapeutics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.

Head office United States
CEO Kevin Tang
Founded 2013
Website www.odonate.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today